TRANSCODE THERAPEUTICS, INC. Contract Liability (Deferred Revenue)
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Contract Liability (Deferred Revenue) of $63.95 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Contract with Customer, Liability, Current $63.95K.
- 2026-03-31: Contract with Customer, Liability, Current $85.26K.
- 2025-12-31: Contract with Customer, Liability, Current $0.00.
- 2025-09-30: Contract with Customer, Liability, Current $0.00.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $63.95K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $85.26K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $25.41K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $25.41K 10-Q · filed 2025-05-14 | $0.00 10-Q · filed 2024-05-15 |
| 2023-12-31 | $27.06K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $54.31K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $81.75K 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 | |
| 2021-12-31 | $30.53K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |